Abstract No. 107: A prospective comparison of the long-term clinical efficacy of temporary stents insertion and pneumatic dilatation for the treatment of achalasia patients
Yue-Qi Zhu,Y. Cheng
DOI: https://doi.org/10.1016/j.jvir.2011.12.148
IF: 3.682
2012-01-01
Journal of Vascular and Interventional Radiology
Abstract:PurposeThe purpose of this study is to compare the long-term clinical efficacy of retrievable self-expanding metallic stents and pneumatic dilation for the treatment of achalasia.Materials and MethodsPatients diagnosed with achalasia (n = 120) were allocated for treatment with pneumatic dilation (n = 30; group A) or a temporary self-expanding metallic stent with a diameter of 20 mm (n = 30; group B), 25 mm (n = 30; group C), or 30 mm (n = 30; group D). Data on clinical symptoms, complications, and long-term clinical outcomes were collected, and follow-up was performed at 6 months and at 1, 3-5, 5-8, 8-10, and more than 10 years after treatment.ResultsPneumatic dilation and stent placement were technically successful in all patients. The follow-up at more than 10 years revealed that the clinical remission rate in group D (83.3%) was higher than that in groups A (0%), B (0%), and C (28.6%), and the overall cumulative clinical failure rate in group D (13%) was lower than that in groups A (76.7%), B (53.3%), and C (26.7%). Patients in group D exhibited reduced dysphagia scores and lower esophageal sphincter pressures and had normal levels of barium height and width during the follow-up periods, whereas these markers increased with time in the other groups. The duration of primary patency in group D (7.10 ± 0.61 years) was also longer than that in groups A (2.50 ± 0.62 years), B (5.90 ± 0.41 years), and C (6.80 ± 0.89 years).ConclusionA temporary self-expanding metallic stent with a diameter of 30 mm has superior clinical efficacy for the treatment of achalasia compared with pneumatic dilation or stents with diameters of 20 or 25 mm. PurposeThe purpose of this study is to compare the long-term clinical efficacy of retrievable self-expanding metallic stents and pneumatic dilation for the treatment of achalasia. The purpose of this study is to compare the long-term clinical efficacy of retrievable self-expanding metallic stents and pneumatic dilation for the treatment of achalasia. Materials and MethodsPatients diagnosed with achalasia (n = 120) were allocated for treatment with pneumatic dilation (n = 30; group A) or a temporary self-expanding metallic stent with a diameter of 20 mm (n = 30; group B), 25 mm (n = 30; group C), or 30 mm (n = 30; group D). Data on clinical symptoms, complications, and long-term clinical outcomes were collected, and follow-up was performed at 6 months and at 1, 3-5, 5-8, 8-10, and more than 10 years after treatment. Patients diagnosed with achalasia (n = 120) were allocated for treatment with pneumatic dilation (n = 30; group A) or a temporary self-expanding metallic stent with a diameter of 20 mm (n = 30; group B), 25 mm (n = 30; group C), or 30 mm (n = 30; group D). Data on clinical symptoms, complications, and long-term clinical outcomes were collected, and follow-up was performed at 6 months and at 1, 3-5, 5-8, 8-10, and more than 10 years after treatment. ResultsPneumatic dilation and stent placement were technically successful in all patients. The follow-up at more than 10 years revealed that the clinical remission rate in group D (83.3%) was higher than that in groups A (0%), B (0%), and C (28.6%), and the overall cumulative clinical failure rate in group D (13%) was lower than that in groups A (76.7%), B (53.3%), and C (26.7%). Patients in group D exhibited reduced dysphagia scores and lower esophageal sphincter pressures and had normal levels of barium height and width during the follow-up periods, whereas these markers increased with time in the other groups. The duration of primary patency in group D (7.10 ± 0.61 years) was also longer than that in groups A (2.50 ± 0.62 years), B (5.90 ± 0.41 years), and C (6.80 ± 0.89 years). Pneumatic dilation and stent placement were technically successful in all patients. The follow-up at more than 10 years revealed that the clinical remission rate in group D (83.3%) was higher than that in groups A (0%), B (0%), and C (28.6%), and the overall cumulative clinical failure rate in group D (13%) was lower than that in groups A (76.7%), B (53.3%), and C (26.7%). Patients in group D exhibited reduced dysphagia scores and lower esophageal sphincter pressures and had normal levels of barium height and width during the follow-up periods, whereas these markers increased with time in the other groups. The duration of primary patency in group D (7.10 ± 0.61 years) was also longer than that in groups A (2.50 ± 0.62 years), B (5.90 ± 0.41 years), and C (6.80 ± 0.89 years). ConclusionA temporary self-expanding metallic stent with a diameter of 30 mm has superior clinical efficacy for the treatment of achalasia compared with pneumatic dilation or stents with diameters of 20 or 25 mm. A temporary self-expanding metallic stent with a diameter of 30 mm has superior clinical efficacy for the treatment of achalasia compared with pneumatic dilation or stents with diameters of 20 or 25 mm.